These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 6588282)
1. [Significance of the determination of serum CA19.9 in patients with tumor or non-tumor pancreatopathies]. Encabo G; Ruibal A; Gefaell R; Martínez Miralles E; Salgado A; Fernández Llamazares J Med Clin (Barc); 1984 Mar; 82(12):560-1. PubMed ID: 6588282 [No Abstract] [Full Text] [Related]
2. [The tumor markers CA 19.9, Ca 50 and CEA in the differential diagnosis of pancreatic carcinoma]. Röthlin M; Metzger U; Joller H; Largiadèr F Schweiz Med Wochenschr; 1988 Jun; 118(24):924-9. PubMed ID: 2456610 [TBL] [Abstract][Full Text] [Related]
3. High serum levels of DUPAN2 antigen and CA19-9 in pancreatic cancer: correlation with immunocytochemical localization of antigens in cancer cells. Suzuki Y; Ichihara T; Nakao A; Sakamoto J; Takagi H; Nagura H Hepatogastroenterology; 1988 Jun; 35(3):128-35. PubMed ID: 3042577 [TBL] [Abstract][Full Text] [Related]
4. Serum levels of the carbohydrate antigen CA-50 in pancreatic disease. Blind PJ; Dahlgren ST Acta Chir Scand; 1987 Jan; 153(1):45-9. PubMed ID: 3472420 [TBL] [Abstract][Full Text] [Related]
5. [Comparison of new three tumor markers for pancreatic carcinoma: CA19/9, CA 125 and DuPan 2]. Ohkura H; Sakawaki T Gan No Rinsho; 1985 May; 31(6 Suppl):583-8. PubMed ID: 3861882 [TBL] [Abstract][Full Text] [Related]
6. [Evaluation of a serum pancreatic tumor marker: the carbohydrate antigen C.A. 19-9]. Vincent D; Venot J; Catanzano G; Clément MN; Piquet MF; Veyriras E; Beck C Ann Med Interne (Paris); 1985; 136(2):142-4. PubMed ID: 3865571 [TBL] [Abstract][Full Text] [Related]
7. [The contribution of CA 19-9 in the differential diagnosis between chronic pancreatitis and cancer of the pancreas]. Van Gossum M; Delanghe A; Gerard M; Delcourt A; Deltenre M Acta Gastroenterol Belg; 1987; 50(1):91-4. PubMed ID: 3480672 [No Abstract] [Full Text] [Related]
8. Carbohydrate antigen (CA 19-9)--a valuable tumor marker of pancreatic cancer. Lin JT; Wang TH; Sung JL; Chen DS Taiwan Yi Xue Hui Za Zhi; 1985 Jul; 84(7):828-35. PubMed ID: 3864924 [No Abstract] [Full Text] [Related]
9. [Attention to CA 19.9 in alcoholics. Apropos of a case]. Giovannini M; Penalvert F; Maillot A; Escoffier JM; Botta D; Gauthier A Ann Gastroenterol Hepatol (Paris); 1987 Dec; 23(7):393. PubMed ID: 3481241 [No Abstract] [Full Text] [Related]
10. [CA 19-9 and cancer of the pancreas. Critical review of the literature]. Delcourt A Acta Gastroenterol Belg; 1987; 50(1):1-8. PubMed ID: 3321822 [No Abstract] [Full Text] [Related]
11. [Serum CA-125 level in patients with gynecologic tumors]. Abe Y; Ueda G; Yamasaki M; Inoue M; Hiramatsu K; Inoue Y; Saito J; Nishino T Rinsho Byori; 1984 Dec; 32(12):1350-4. PubMed ID: 6597876 [No Abstract] [Full Text] [Related]
12. [Serum tissue polypeptide antigen in the differential diagnosis of chronic pancreatitis and exocrine pancreatic tumors. Preliminary results]. Ruibal A; Encabo G Rev Esp Oncol; 1983; 30(3):313-6. PubMed ID: 6571374 [TBL] [Abstract][Full Text] [Related]
13. Serum CA 242 in pancreatic cancer. Comparison with CA 19-9 and CEA. Pezzilli R; Billi P; Plate L; Laudadio MA; Sprovieri G Ital J Gastroenterol; 1995; 27(6):296-9. PubMed ID: 8562994 [TBL] [Abstract][Full Text] [Related]
14. [A new carbohydrate antigen CA19-9 associated with malignancies of digestive system. II. Serum levels of CA19-9 in various digestive diseases and their clinical significance]. Yamanaka T; Kitagawa Y; Seki H; Kimura K; Sakurabayashi I; Kawai T Rinsho Byori; 1984 Jul; 32(7):786-92. PubMed ID: 6594536 [No Abstract] [Full Text] [Related]
15. [Clinical evaluation of a cancer antigen, CA 15-3, associated with breast cancer. (I) Modification of its method and reference values]. Sakurabayashi I; Kawai T; Kawaguchi R; Yonezawa M Rinsho Byori; 1986 Jan; 34(1):53-8. PubMed ID: 3457966 [No Abstract] [Full Text] [Related]
16. [Clinical evaluation of a cancer antigen, CA 125, associated with ovarian cancer. I. Technical investigation and the reference value]. Sakurabayashi I; Kawai T; Suzuki M; Tamada T; Sato K; Yonezawa M Rinsho Byori; 1984 Dec; 32(12):1345-9. PubMed ID: 6597875 [No Abstract] [Full Text] [Related]
17. [CA 19-9, a new tumor marker]. Akai S Rinsho Byori; 1983 Dec; 31(12):1300-2. PubMed ID: 6587136 [No Abstract] [Full Text] [Related]
18. The distribution and localization of the monoclonal antibody-defined antigen 19-9 (CA19-9) in chronic pancreatitis and pancreatic carcinoma. An immunohistochemical study. Makovitzky J Virchows Arch B Cell Pathol Incl Mol Pathol; 1986; 51(6):535-44. PubMed ID: 2878526 [TBL] [Abstract][Full Text] [Related]
19. [The tumor-associated antigen CA 19-9 in the differential diagnosis and course control of malignancies of the pancreas and the gastrointestinal tract]. Klapdor R; Greten H Dtsch Med Wochenschr; 1984 Dec; 109(50):1935-9. PubMed ID: 6210188 [No Abstract] [Full Text] [Related]
20. Combined detection of serum tumor markers for differential diagnosis of solid lesions located at the pancreatic head. Liao Q; Zhao YP; Yang YC; Li LJ; Long X; Han SM Hepatobiliary Pancreat Dis Int; 2007 Dec; 6(6):641-5. PubMed ID: 18086633 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]